Literature DB >> 29725411

Efficacy of extracts of Celastrus orbiculatus in suppressing migration and invasion by inhibiting the EZH2/ROCK1 signaling pathway in human nasopharyngeal carcinoma.

Xuanyi Wang1,2, Yuxiang Huang3, Yong Chen4, Yong Ma4, Fei Yang4, Yayun Qian2, Xiaojun Dai5, Lede Tao2, Haibo Wang2, Renhua Guo6, Yanqing Liu2.   

Abstract

Celastrus orbiculatus extract (COE) has been used in folk medicine in China for the treatment of a number of diseases. In the laboratory, COE exhibits a variety of anticancer functions, including inhibition of metastasis. However, the underlying molecular anti-metastatic mechanism in nasopharyngeal carcinoma (NPC) cells remains unclear. The aim of the present study was to determine whether the anti-metastatic effect of COE was involved in inhibiting migration and invasion of human NPC cells. In vitro, cell viability and apoptosis of 5-8F cells were analyzed using an MTS assay and flow cytometry, respectively. Invasion and migration of 5-8F cells were analyzed using a Transwell assay. Protein and mRNA expression levels of 5-8F cells were analyzed by western blot analysis and the reverse transcription-quantitative polymerase chain reaction, respectively. COE significantly decreased cell viability in 5-8F cells and inhibited enhancer of zeste homolog 2 (EZH2) and Rho-associated coiled coil-containing protein kinase 1 (ROCK1) expression at the mRNA and protein levels. Furthermore, COE decreased the migration and invasion of 5-8F cells in a dose-dependent manner. The results of the present study suggested that COE prevents migration and invasion by suppressing the EZH2/ROCK1 signaling pathway in NPC cells. On the basis of the results of the present study, COE may be a novel anticancer agent for the treatment of metastasis in NPC.

Entities:  

Keywords:  Celastrus orbiculatus; Rho-associated coiled-coil containing protein kinase 1; enhancer of zeste homolog 2; invasion; nasopharyngeal carcinoma

Year:  2018        PMID: 29725411      PMCID: PMC5920271          DOI: 10.3892/ol.2018.8149

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  21 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Antimetastatic effects of Celastrus orbiculatus on human gastric adenocarcinoma by inhibiting epithelial-mesenchymal transition and NF-κB/snail signaling pathway.

Authors:  Yaodong Zhu; Yanqing Liu; Yayun Qian; Xiaojun Dai; Lin Yang; Jue Chen; Shiyu Guo; Tadashi Hisamitsu
Journal:  Integr Cancer Ther       Date:  2015-02-26       Impact factor: 3.279

Review 3.  Polycomb genes and cancer: time for clinical application?

Authors:  Francesco Crea; Elisa Paolicchi; Victor E Marquez; Romano Danesi
Journal:  Crit Rev Oncol Hematol       Date:  2011-11-22       Impact factor: 6.312

4.  Celastrus orbiculatus extract inhibits tumor angiogenesis by targeting vascular endothelial growth factor signaling pathway and shows potent antitumor activity in hepatocarcinomas in Vitro and in Vivo.

Authors:  Ya-yun Qian; Hua Zhang; Ying Hou; Lin Yuan; Guo-qing Li; Shi-yu Guo; Tadashi Hisamits; Yan-qing Liu
Journal:  Chin J Integr Med       Date:  2011-07-30       Impact factor: 1.978

Review 5.  The battle against nasopharyngeal cancer.

Authors:  Anne W M Lee; W T Ng; Y H Chan; Henry Sze; Connie Chan; T H Lam
Journal:  Radiother Oncol       Date:  2012-08-30       Impact factor: 6.280

6.  Enhancer of zeste homolog 2 overexpression in nasopharyngeal carcinoma: an independent poor prognosticator that enhances cell growth.

Authors:  Chung-Feng Hwang; Hsuan-Ying Huang; Chang-Han Chen; Chih-Yen Chien; Yao-Chung Hsu; Chien-Feng Li; Fu-Min Fang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-06       Impact factor: 7.038

Review 7.  The role of EZH2 in tumour progression.

Authors:  C-J Chang; M-C Hung
Journal:  Br J Cancer       Date:  2011-12-20       Impact factor: 7.640

8.  ROCK1 and 2 differentially regulate actomyosin organization to drive cell and synaptic polarity.

Authors:  Karen A Newell-Litwa; Mathilde Badoual; Hannelore Asmussen; Heather Patel; Leanna Whitmore; Alan Rick Horwitz
Journal:  J Cell Biol       Date:  2015-07-13       Impact factor: 10.539

9.  3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells.

Authors:  Nicolas Girard; Céline Bazille; Eva Lhuissier; Hervé Benateau; Antonio Llombart-Bosch; Karim Boumediene; Catherine Bauge
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

10.  Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis.

Authors:  Xinhua Wang; Hongqing Zhao; Lei Lv; Liang Bao; Xun Wang; Shuguang Han
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.